查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918173

穿戴式装置在气喘管理的应用－2026-2031年预测

Wearables for Asthma Management Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计气喘管理穿戴装置市场将维持 8.16% 的复合年增长率，从 2025 年的 991,559,000 美元成长到 2031 年的 1,587,315,000 美元。

专用于气喘管理的穿戴式装置市场正在迅速扩张，标誌着慢性呼吸系统疾病治疗模式的重大转变。这些技术超越了传统的被动监测，提供数据驱动的主动管理工具，从而增强患者的自主性并革新临床决策。

核心价值提案与临床需求

气喘穿戴装置的根本价值在于其能够持续、即时地提供患者呼吸状况和环境资讯。透过监测呼吸模式、肺功能和吸气动态等关键生理参数，这些设备可以建构疾病的全面纵向图谱。这种持续的数据流使得早期发现气喘急性发作的预警讯号成为可能，远比常规症状报告或诊室肺功能检查所能达到的更早。

这项功能满足了一项重要的临床需求：预防严重气喘发作并减少相关的急性医疗事件。显着减少气喘相关住院和急诊就诊的潜力，对医疗保健系统而言意义重大。透过促进及时干预，例如药物调配、避免诱发因素和咨询医生，穿戴式装置有助于控制症状、提高生活质量，并减轻急诊和住院服务的整体负担。

主要市场驱动因素

市场扩张是由多种协同因素所驱动的。气喘在全球持续高发生率，导致庞大且稳定的患者族群亟需有效的管理方案。穿戴式感测器技术的同步发展正满足这项临床需求，使得更小巧、更精准、更易用的设备得以开发，能够可靠地追踪复杂的呼吸指标。

病人赋能和积极自我管理的文化转变是推动穿戴式装置普及的关键因素。患者越来越希望在自身健康管理中扮演积极的角色，而穿戴式装置恰好为他们提供了所需的工具。这些设备能够直接向使用者提供关于症状、诱发因素和用药依从性的个人化讯息，从而将气喘管理从被动应对转变为主动预防。这种日益增强的自我管理意识和需求与穿戴式科技的功能完美契合。

此外，远端患者监护和远端医疗与标准护理模式的广泛融合正在加速市场接受度。穿戴式装置作为这些虚拟照护路径中的数据生成前端，为临床医生提供客观的真实世界数据，以指导远距照护协调，从而与改善传统临床环境之外的慢性病管理这一系统性目标相契合。

市场区隔与技术整合

该市场围绕着核心功能构建，由既独立又相互重迭的细分市场组成。其中一个主要细分市场专注于生理监测，利用穿戴式感测器追踪肺功能、呼吸频率和其他生命征象。另一个重要细分市场围绕着药物依从性和管理展开，利用连网智慧吸入器和感测器记录使用数据，包括每次用药的时间、方法和环境背景。

这些资料流的融合才能真正发挥最大价值。前沿解决方案将生理监测数据与用药数据和环境数据（例如花粉计数、空气品质）相结合，从而全面了解个体的气喘状况。这种整合方法能够提供真正个人化的洞察，识别特定的诱发因素，并评估处方疗法在实际应用中的有效性。

区域创新中心

北美凭藉先进的医疗基础设施、高气喘盛行率以及强大的数位医疗创新生态系统，在该市场保持主导地位。该地区专注于以价值为导向的医疗保健和慢性病管理，为那些能够改善疗效并降低成本的技术创造了有利环境。北美医疗技术公司、製药公司、医疗服务提供者和学术机构之间的积极合作，促进了产品的持续研发和临床检验。

竞争格局与解决方案原型

竞争格局多元化，既有专注于数位医疗领域的公司，也有医疗设备与製药公司之间的合作专案。主要竞争对手的差异体现在各自的技术重点、数据分析能力以及与更广泛医疗平台的整合。

关键解决方案原型包括用于监测肺功能和呼吸模式的专用可穿戴监测器，以及可连接到现有吸入器以追踪使用情况的智慧吸入器感测器，通常与复杂的行动应用程式配合使用，以整合数据、向患者提供反馈和教育，并促进与医疗保健提供者以及在某些情况下与看护者的数据共用。

未来发展及策略意义

该市场的未来发展将侧重于更深入的临床整合和更先进的预测能力。未来的发展将着重于增强这些平台内建的预测分析能力，从说明数据报告转向指导性警报和个人化建议。利用人工智慧辨识个别病情加重的征兆将是一项关键的尖端技术。

另一个重要发展是向多疾病平台转型，气喘管理将成为更广泛的呼吸系统和慢性病管理生态系统中的一个模组。与电子健康记录和远端医疗平台的互通性对于在医疗保健系统中广泛应用也至关重要。

对相关人员而言，成功与否取决于能否透过改善健康结果和降低急诊护理成本来证明其具有明显的临床效用和投资回报。透过临床研究累积可靠的证据、建立将软体作为医疗设备的监管途径，以及确保流畅的使用者体验以维持病人参与，这些都是关键的策略重点。用于气喘管理的可穿戴设备将成为以患者为中心的现代化预防性呼吸系统健康方法的重要组成部分。

本报告的主要优势：

  • 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索市场驱动因素和关键趋势，以及它们将如何塑造未来的市场发展。
  • 可操作的建议：利用这些见解，在动态环境中做出策略决策，并开拓新的商机和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

它是用来做什么的？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

第五章气喘管理穿戴装置市场（按类型划分）

  • 介绍
  • 智慧吸入器
  • 穿戴式肺功能监测器
  • 具备气喘监测功能的活动追踪器

6. 按技术分類的气喘管理穿戴装置市场

  • 介绍
  • 蓝牙连接
  • 感测器技术
  • 行动应用与平台

第七章 依应用分類的气喘管理穿戴装置市场

  • 介绍
  • 气喘症状监测
  • 药物依从性追踪
  • 峰值流速监测
  • 识别触发因素
  • 个人化气喘管理

第八章 按最终用户分類的气喘管理穿戴式装置市场

  • 介绍
  • 气喘患者
  • 医疗保健提供者
  • 医院和诊所
  • 研究所

9. 各地区气喘管理穿戴装置市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十一章：公司简介

  • Propeller Health（Now Part Of Resmed）
  • Adherium Limited
  • Teva Pharmaceuticals
  • Cohero Health
  • Nuvoair
  • Astrazeneca Plc
  • Health Care Originals
  • Inspirx, Inc.
  • Amiko Digital Health Limited
  • Healthimation, Llc

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615993

Wearables For Asthma Management Market, sustaining a 8.16% CAGR, is forecasted to rise from USD 991.559 million in 2025 to USD 1587.315 million in 2031.

The market for wearable devices dedicated to asthma management is expanding rapidly, representing a significant shift in the paradigm of chronic respiratory care. These technologies are moving beyond traditional passive monitoring to offer proactive, data-driven management tools that empower patients and transform clinical decision-making.

Core Value Proposition and Clinical Imperative

The fundamental value of asthma wearables lies in their ability to provide continuous, real-time insights into a patient's respiratory status and environmental context. By monitoring key physiological parameters such as breathing patterns, lung function, and inhalation mechanics, these devices create a comprehensive, longitudinal profile of the disease. This continuous data stream enables the detection of early warning signs of exacerbation, far earlier than periodic symptom reporting or spirometry in a clinic can achieve.

This capability addresses a critical clinical need: the prevention of severe asthma attacks and the reduction of associated acute care events. The potential to significantly decrease asthma-related hospitalizations and emergency room visits represents a primary value driver for healthcare systems. By facilitating timely interventions-such as adjusting medication, avoiding triggers, or consulting a provider-wearables can help maintain control, improve quality of life, and reduce the overall burden on emergency and inpatient services.

Key Market Growth Drivers

Market expansion is fueled by several synergistic factors. The persistent and high global prevalence of asthma establishes a substantial and sustained patient population in need of effective management solutions. This clinical demand is met by parallel advancements in wearable sensor technology, which have enabled the development of smaller, more accurate, and more user-friendly devices capable of reliably tracking complex respiratory metrics.

A powerful cultural shift toward patient empowerment and proactive self-management is a critical adoption driver. Patients are increasingly seeking active roles in their healthcare, and wearables provide the necessary tools. By delivering personalized insights on symptoms, triggers, and medication adherence directly to the user, these devices transform asthma management from a reactive to a proactive endeavor. This growing awareness and desire for self-care aligns perfectly with the functionality of wearable technologies.

Furthermore, the broader integration of remote patient monitoring and telehealth into standard care models accelerates market acceptance. Wearables serve as the data-generating front end for these virtual care pathways, providing clinicians with objective, real-world evidence to guide treatment adjustments remotely. This aligns with systemic goals to improve chronic disease management outside traditional clinical settings.

Market Segmentation and Technological Integration

The market comprises distinct but overlapping segments centered on core functionalities. A primary segment is focused on physiological monitoring, utilizing wearable sensors to track lung function, respiratory rate, and other biometrics. A second, crucial segment revolves around medication adherence and management, featuring connected smart inhalers and sensors that record usage data, including timing, technique, and environmental context of each dose.

The convergence of these data streams is where maximal value is created. The most advanced solutions integrate physiological monitoring with medication use and environmental data (e.g., pollen count, air quality) to build a holistic understanding of an individual's asthma. This integrated approach enables truly personalized insights, identifying specific triggers and evaluating the real-world effectiveness of prescribed therapies.

Geographic Landscape and Innovation Hubs

North America maintains a leadership position in this market, driven by a confluence of advanced healthcare infrastructure, a high prevalence of asthma, and a robust ecosystem for digital health innovation. The region's focus on value-based care and chronic disease management creates a receptive environment for technologies that demonstrate improved outcomes and cost savings. Active collaboration between medical technology companies, pharmaceutical firms, healthcare providers, and academic institutions in North America fosters continuous product development and clinical validation.

Competitive Landscape and Solution Archetypes

The competitive landscape features a diverse array of players, including specialized digital health companies and partnerships between device manufacturers and pharmaceutical entities. Key competitors are differentiated by their specific technological focus, data analytics capabilities, and integration into broader care platforms.

Primary solution archetypes include dedicated wearable monitors for lung function and breathing patterns, and smart inhaler sensors that attach to existing inhalers to track usage. These are typically paired with sophisticated mobile applications that aggregate data, provide patient feedback and education, and facilitate data sharing with healthcare providers and, in some cases, caregivers.

Future Trajectory and Strategic Implications

The forward trajectory for this market points toward deeper clinical integration and more intelligent predictive capabilities. Future development will focus on enhancing the predictive analytics embedded within these platforms, moving from descriptive data reporting to prescriptive alerts and personalized recommendations. The integration of artificial intelligence to identify individual exacerbation precursors represents a significant frontier.

Another key evolution will be the move toward multi-condition platforms, where asthma management is one module within a broader respiratory or chronic disease management ecosystem. Interoperability with electronic health records and telehealth platforms will also be critical for scaling adoption within health systems.

For industry stakeholders, success will depend on demonstrating clear clinical utility and a return on investment through improved health outcomes and reduced acute care costs. Building robust evidence through clinical studies, navigating regulatory pathways for software as a medical device, and ensuring seamless user experiences to maintain patient engagement are all critical strategic priorities. Wearables for asthma management are poised to become an indispensable component of a modern, preventative, and patient-centered approach to respiratory health.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Wearables for Asthma Management Market Segmentation

  • By Type
  • Smart Inhalers
  • Wearable Spirometers
  • Activity Trackers With Asthma Monitoring
  • By Technology
  • Bluetooth Connectivity
  • Sensor Technology
  • Mobile Apps And Platforms
  • By Application
  • Asthma Symptom Monitoring
  • Medication Adherence Tracking
  • Peak Flow Rate Monitoring
  • Trigger Identification
  • Personalized Asthma Management
  • By End-User
  • Patients With Asthma
  • Healthcare Providers
  • Hospitals And Clinics
  • Research Institutions
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Smart Inhalers
  • 5.3. Wearable Spirometers
  • 5.4. Activity Trackers With Asthma Monitoring

6. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Bluetooth Connectivity
  • 6.3. Sensor Technology
  • 6.4. Mobile Apps And Platforms

7. WEARABLE FOR ASTHMA MANAGEMENT MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Asthma Symptom Monitoring
  • 7.3. Medication Adherence Tracking
  • 7.4. Peak Flow Rate Monitoring
  • 7.5. Trigger Identification
  • 7.6. Personalized Asthma Management

8. WEARABLE FOR ASTHMA MANAGEMENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Patients With Asthma
  • 8.3. Healthcare Providers
  • 8.4. Hospitals And Clinics
  • 8.5. Research Institutions

9. WEARABLE FOR ASTHMA MANAGEMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Propeller Health (Now Part Of Resmed)
  • 11.2. Adherium Limited
  • 11.3. Teva Pharmaceuticals
  • 11.4. Cohero Health
  • 11.5. Nuvoair
  • 11.6. Astrazeneca Plc
  • 11.7. Health Care Originals
  • 11.8. Inspirx, Inc.
  • 11.9. Amiko Digital Health Limited
  • 11.10. Healthimation, Llc

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations